TMCnet News

Research and Markets: Colorectal Cancer - Pipeline Review, H1 2015 - Reviews Key Players Involved in the Therapeutics Development for Colorectal Cancer
[August 14, 2015]

Research and Markets: Colorectal Cancer - Pipeline Review, H1 2015 - Reviews Key Players Involved in the Therapeutics Development for Colorectal Cancer


Research and Markets (http://www.researchandmarkets.com/research/r7zhzc/colorectal_cancer) has announced the addition of the "Colorectal Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

  • The report reviews key pipeline products under drug profile section whichincludes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • A review of the Colorectal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources



Key Topics Covered:

  • Colorectal Cancer Overview
  • Therapeutics Development
  • Therapeutics under Development by Companies
  • Therapeutics under Investigation by Universities/Institutes
  • Pipeline Products Glance
  • Products under Development by Companies
  • Products under Investigation by Universities/Institutes
  • Companies Involved in Therapeutics Development
  • Therapeutics Assessment
  • Drug Profiles
  • Recent Pipeline Updates
  • Dormant Projects
  • Discontinued Products
  • Product Development Milestones

Companies Mentioned


  • 2cureX ApS
  • 3-V Biosciences, Inc.
  • 4SC AG
  • AB Science
  • AbbVie Inc.
  • Actinium Pharmaceuticals, Inc.
  • Adamed Sp. z o.o.
  • Advaxis, Inc.
  • Advenchen Laboratories, LLC
  • Aeterna Zentaris Inc.
  • Alchemia Limited
  • Allinky Biopharma
  • Amgen Inc.
  • Angiogene Pharmaceuticals Limited
  • Antibe Therapeutics, Inc.
  • Aphios Corporation
  • Arisaph Pharmaceuticals, Inc.
  • ArQule, Inc.
  • Array BioPharma Inc.
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • AstraZeneca Plc
  • AVEO Pharmaceuticals, Inc.
  • Basilea Pharmaceutica AG
  • Bavarian Nordic A/S
  • Bayer AG
  • Beta Cat Pharmaceuticals, LLC
  • Biocon Limited
  • Bionomics Limited
  • BioNovion B.V.
  • Biothera, Inc.
  • Boehringer Ingelheim GmbH
  • Boston Biomedical, Inc.
  • Bristol-Myers Squibb Company

For more information visit http://www.researchandmarkets.com/research/r7zhzc/colorectal_cancer


[ Back To TMCnet.com's Homepage ]